Altshuler Shaham’s Corcept Therapeutics CORT Stock Holding History

Altshuler Shaham’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$115	Sell	1 -99	-99%	-$10.6K	﹤0.01%	510
2026 Q2	$8.7K	Hold	100	–	–	﹤0.01%	331
2026 Q1	$4.03K	Sell	100 -100	-50%	-$3.74K	﹤0.01%	320
2025 Q4	$6.96K	Buy	200 +141	+239%	+$11.1K	﹤0.01%	267
2025 Q3	$4.9K	Hold	59	–	–	﹤0.01%	250
2025 Q2	$4.33K	Sell	59 -10	-14%	-$725	﹤0.01%	245
2025 Q1	$7.88K	Buy	+69	New	+$4.2K	﹤0.01%	201
2023 Q4	–	Sell	-728	Closed	-$19.8K	–	273
2023 Q3	$19.8K	Buy	+728	New	+$21.1K	﹤0.01%	254
2023 Q1	–	Sell	-2,580	Closed	-$52.4K	–	396
2022 Q4	$52.4K	Buy	2,580 +294	+13%	+$7.37K	﹤0.01%	207
2022 Q3	$58K	Buy	2,286 +922	+68%	+$24.7K	﹤0.01%	195
2022 Q2	$32K	Sell	1,364 -226	-14%	-$4.92K	﹤0.01%	308
2022 Q1	$36K	Buy	+1,590	New	+$33.8K	﹤0.01%	455
2020 Q3	–	Sell	-1,352	Closed	-$23K	–	389
2020 Q2	$23K	Buy	+1,352	New	+$19K	﹤0.01%	248

Other funds holding CORT

Ingalls & Snyder LLC New York $3.91B AUM 60.54% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Altshuler Shaham's CORT Position: Q3 2026 in Review

Altshuler Shaham reduced its Corcept Therapeutics (CORT) stake by 99% in Q3 2026, selling an estimated $10.6K and leaving 1 share worth $115. The position accounts for ﹤0.01% of the portfolio, ranked #510.

Altshuler Shaham first reported a position in CORT in Q2 2020 and has held it in 13 quarters since. The position peaked at $58K in Q3 2022. 339 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

Altshuler Shaham held 1 share of Corcept Therapeutics worth $115 as of Q3 2026.
Altshuler Shaham sold 99 Corcept Therapeutics shares in Q3 2026, an estimated $10.6K.
Corcept Therapeutics made up ﹤0.01% of Altshuler Shaham's portfolio in Q3 2026, its #510 holding.
Altshuler Shaham first reported a position in Corcept Therapeutics in Q2 2020 and has held it in 13 quarters since.
Altshuler Shaham's Corcept Therapeutics position peaked at $58K in Q3 2022.
339 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Altshuler Shaham's 13F filing for Q3 2026, filed 12 Nov 2026.